Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RSPH vs. RAGHX: which is better?

Bottom line

RSPH vs RAGHX: the short answer

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and RAGHX (Virtus KAR Health Sciences Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.

But RSPH is far broader, holding 63 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.

RSPH is cheaper at 0.4% vs 1.41% — a difference of $101 a year per $10,000 invested.

Over five years, RSPH returned +4.7% a year vs +2.4% for RAGHX.

RAGHX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

RSPH vs RAGHX side by side

RSPHRAGHX
TypeETFMutual fund
Fund familyInvescoVirtus
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.4%1.41%
Annual cost per $10k$40$141
10-yr cost on $10k (prospectus)$505$2,148
Max front loadNone5.5%
12b-1 fee—0.25%
1-yr return+9.3%+1.3%
5-yr return (annualized)+4.7%+2.4%
10-yr return (annualized)+8.2%+6.2%
Best quarter+17.5%—
Worst quarter−14.3%—
Net assets (fund)$766.9M$91.7M
Number of holdings6324
Portfolio turnover24%13%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

6 of RSPH's top 25 holdings also appear in RAGHX's top 24.

Shared top holdings
HoldingRSPHRAGHX
Regeneron Pharmaceuticals, Inc.1.96%2.90%
Mettler-Toledo International Inc.1.94%3.99%
Thermo Fisher Scientific Inc.1.84%3.65%
Amgen Inc.1.77%3.85%
DexCom, Inc.1.73%3.05%
AbbVie Inc.1.73%5.52%

Source: SEC Form N-PORT

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

RAGHX top 10

  1. Eli Lilly & Company — 14.84%
  2. West Pharmaceutical Services Inc — 5.92%
  3. Abbvie Inc — 5.52%
  4. Vertex Pharmaceuticals Inc — 5.32%
  5. Merck & Company Inc — 5.06%
  6. Unitedhealth Group Inc — 4.65%
  7. Mckesson Corp — 4.57%
  8. Mettler-toledo International Inc — 3.99%
  9. Intuitive Surgical Inc — 3.89%
  10. Amgen Inc — 3.85%

FAQ

What is the difference between RSPH and RAGHX?
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and RAGHX (Virtus KAR Health Sciences Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared. But RSPH is far broader, holding 63 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
Which is cheaper, RSPH or RAGHX?
RSPH has the lower expense ratio (0.4%).
Should I own both RSPH and RAGHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.